GustID. The epidemiology of viral hepatitis. In: VyasGN eds. Viral hepatitis and liver disease. Orlando: Grune & Stratton, 1984:415–21.
2.
TandonBNJoshiYKJainSK.An epidemic of nonA nonB hepatitis in north India. Indian J Med Res1982;75:739–44.
3.
KhurooMS.Study of an epidemic of nonA nonB hepatitis: Possibility of another human hepatitis virus distinct from post-transfusion nonA nonB type. Am J Med1980;68:818–24.
4.
RizettoMCaneseMGAricoSImmunofluorescence detection of a new antigen-antibody system (delta/anti-delta) associated with hepatitis B virus in liver and in serum of HBbsAg carriers. Gut1977;18:997–1003.
5.
HadlerSCde MonzonMPonzettoAAn epidemic of severe hepatitis due to delta virus infection in Yucpa Indians in Venezuela. Ann Intern Med1984;100:339–44.
6.
LednarWMLemonSMKirkpatrickJWRedfieldRRFieldsMLKelleyPW.Frequency of illness associated with hepatitis A virus infection in adults. Am J Epidemiol1985;122:226–33.
7.
HoofnagleJH.Chronic type B hepatitis. Gastroenterology1983;84:422–3.
8.
HillemanMRMcAleerWJBuynakEBMcLeanAA.Quality and safety of human hepatitis B vaccine. In: Developments in biological standardisation . Proceedings of the 2nd International IABS/WHO symposium on viral hepatitis.Basel: Karger, 1983:54:3–12.
9.
RyderRWWhittleHCWojiecowskyT. Screening for hepatitis B virus markers is not justified in West African transfusion centres. Lancet1984;ii:449–52.
10.
ChuC-MKarayiannisPFowlerMJFMongiardinoJLiawY-FThomasHC.Natural History of chronic hepatitis B virus infection in Taiwan: Studies of HBV DNA in serum. Hepatology1985;5:431–4.
11.
AyooloEA.Vaccination against hepatitis B in Nigerian children. Trials of reduced dose and intradermal vaccine. J Trop Pediatr1985;31:253–6.
12.
ZuckermanAJ.New hepatitis B vaccines. Br Med J1985;290:492–6.